TrialBioMed research international2015

Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A" Success Rate for First-Line Helicobacter pylori Eradication.

Wei-Chen Tai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.